The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Aikaterini.Miari@glasgow.ac.uk
21 Shelley Road, Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Gartnavel General Hospital, G12 0ZD
Sun, J. et al. (2024) IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia, 38(11), pp. 2355-2365. (doi: 10.1038/s41375-024-02391-8) (PMID:39215060) (PMCID:PMC11518999)
Miari, K. E. and Williams, M. T. S. (2024) Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. British Journal of Pharmacology, 181(2), pp. 216-237. (doi: 10.1111/bph.16028) (PMID:36609915)
Miari, K. E. , Guzman, M. L., Wheadon, H. and Williams, M. T. S. (2021) Macrophages in Acute Myeloid Leukaemia: significant players in therapy resistance and patient outcomes. Frontiers in Cell and Developmental Biology, 9, 692800. (doi: 10.3389/fcell.2021.692800) (PMID:34249942) (PMCID:PMC8264427)
Sun, J. et al. (2024) IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia, 38(11), pp. 2355-2365. (doi: 10.1038/s41375-024-02391-8) (PMID:39215060) (PMCID:PMC11518999)
Miari, K. E. and Williams, M. T. S. (2024) Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. British Journal of Pharmacology, 181(2), pp. 216-237. (doi: 10.1111/bph.16028) (PMID:36609915)
Miari, K. E. , Guzman, M. L., Wheadon, H. and Williams, M. T. S. (2021) Macrophages in Acute Myeloid Leukaemia: significant players in therapy resistance and patient outcomes. Frontiers in Cell and Developmental Biology, 9, 692800. (doi: 10.3389/fcell.2021.692800) (PMID:34249942) (PMCID:PMC8264427)
https://orcid.org/0000-0003-3008-966X